Nurith Aizenman
-
Tuberculosis kills 1.6 million a year — the second deadliest infectious disease after COVID-19. Using immune cells and mRNA technology, scientists in South Africa are working on a new vaccine.
-
That's the view of Joseph Glauber of the International Food Policy Research Institute. He considers the fear the war would lead to a surge in food prices – and a dramatic worsening of world hunger.
-
The mRNA shots against COVID were a game-changer but the shots need ultra-cold freezers that are unavailable in many low-income countries. Now the hunt is on for innovations to solve this problem.
-
Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed?
-
Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter.
-
Can we end poverty, provide food for all and otherwise make Earth a better place by 2030? By all accounts, the answer is no. So then what's the point of the Sustainable Development Goals?
-
Only one company makes the currently used monkeypox vaccine. Supply is limited in wealthy nations like the U.S. Less well-off nations, like Nigeria, where the outbreak began, have no vaccines at all.
-
Pfizer and Moderna have refused to divulge details of how to make their cutting-edge COVID shots. Here's what two scientists — and longtime best friends — are doing about it.
-
Two women in Uvalde are spearheading an effort to soothe their community with food. Because Uvalde's resident's lives are so intertwined, everyone knows someone affected by the massacre.
-
The U.S. has pulled back funding for global vaccinations. Some countries — like Brazil — don't need the help. Vaccination rates remain low in other countries such as Iraq due to issues of mistrust.